Benzinga | Oct 14, 2020 08:47AM EDT

Roth Capital Maintains Buy on Eyenovia, Lowers Price Target to $11

Roth Capital maintains Eyenovia (NASDAQ:EYEN) with a Buy and lowers the price target from $14 to $11.